Table 1.

Revised classification criteria for the antiphospholipid antibody syndrome.14 

Clinical criteria (one or more)
  1. Vascular thrombosis: One or more objectively confirmed episodes of arterial, venous or small vessel thrombosis occurring in any tissue or organ

  2. Pregnancy morbidity:

    • one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week of gestation; or

    • one or more premature births of a morphologically normal neonate before the 34th week of gestation because of eclampsia, pre-eclampsia or placental insufficiency; or

    • Three or more unexplained consecutive spontaneous abortions before the 10th week of gestation

 
Laboratory criteria (one or more, present on 2 or more occasions at least 12 weeks apart using recommended procedures)
  1. Lupus anticoagulant, detected according to the guidelines of the International Society on Thrombosis and Haemostasis

  2. Anticardiolipin antibody of IgG and/or IgM isotype, present in medium or high titer (greater than 40 GPL or MPL, or greater than the 99th percentile), measured by a standardized ELISA

  3. Anti-β2-glycoprotein-1 antibody of IgG and/or IgM isotype, present in titer greater than the 99th percentile, measured by a standardized ELISA

 
Clinical criteria (one or more)
  1. Vascular thrombosis: One or more objectively confirmed episodes of arterial, venous or small vessel thrombosis occurring in any tissue or organ

  2. Pregnancy morbidity:

    • one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week of gestation; or

    • one or more premature births of a morphologically normal neonate before the 34th week of gestation because of eclampsia, pre-eclampsia or placental insufficiency; or

    • Three or more unexplained consecutive spontaneous abortions before the 10th week of gestation

 
Laboratory criteria (one or more, present on 2 or more occasions at least 12 weeks apart using recommended procedures)
  1. Lupus anticoagulant, detected according to the guidelines of the International Society on Thrombosis and Haemostasis

  2. Anticardiolipin antibody of IgG and/or IgM isotype, present in medium or high titer (greater than 40 GPL or MPL, or greater than the 99th percentile), measured by a standardized ELISA

  3. Anti-β2-glycoprotein-1 antibody of IgG and/or IgM isotype, present in titer greater than the 99th percentile, measured by a standardized ELISA

 
Close Modal

or Create an Account

Close Modal
Close Modal